01.08.2012 | Case report
Cisplatin/doxorubicin/epirubicin
Hepatitis C reactivation: 4 case reports
Erschienen in: Reactions Weekly | Ausgabe 1/2012
Einloggen, um Zugang zu erhaltenExcerpt
An event is serious (FDA MedWatch definition) when the patient outcome is:-
death
-
life-threatening
-
hospitalisation
-
disability
-
congenital anomaly
-
requires intervention to prevent permanent impairment or damage